Post by
TechTarget on Nov 01, 2015 10:13am
Revenues of $1.02-billion (U.S.) to $1.06-billion (U.S.)
CXR was unfairly associiated with the whole Turing Pharmaceutical price gouging and then the VRX uncertainties and well known short seller attack.
Comment by
adamchess on Nov 01, 2015 4:17pm
Nothing to do with CRX. Please move on.
Comment by
ruben12345 on Nov 01, 2015 4:55pm
This would actually be good for CXR. LEts get the word on VRX out and we can move on